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Edited by Masayuki MiyasakaAbstract Early during infection neutrophils are the most impor-
tant immune cells that are involved in killing of pathogenic bac-
teria and regulation of innate immune responses at the site of
infection. It has become clear that neutrophils also modulate
adaptive immunity through interactions with dendritic cells
(DCs) that are pivotal in the induction of T cell responses. Upon
activation, neutrophils release TNF-a and induce maturation of
DCs that enables these antigen-presenting cells to stimulate T
cell proliferation and to induce T helper 1 polarization. DC mat-
uration by neutrophils also requires cellular interactions that are
mediated by binding of the DC-speciﬁc receptor DC-SIGN to
Mac-1 on the neutrophil. Here, we demonstrate that also CEA-
CAM1 is an important ligand for DC-SIGN on neutrophils.
Binding of DC-SIGN to both CEACAM1 and Mac-1 is required
to establish cellular interactions with neutrophils. DC-SIGN is a
C-type lectin that has speciﬁcity for Lewisx, and we show that
DC-SIGN mediates binding to CEACAM1 through Lewisx moi-
eties that are speciﬁcally expressed on CEACAM1 derived from
neutrophils. This indicates that glycosylation-driven binding of
both Mac-1 and CEACAM1 to DC-SIGN is essential for inter-
actions of neutrophils with DCs and enables neutrophils to mod-
ulate T cell responses through interactions with DCs.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Neutrophils are important in early immunity to bacterial
infection. The early arrival of neutrophils at the site of infection
depends on their ability to rapidly respond to chemotactic stim-
uli released by bacteria and inﬂamed epithelium.At the infection
site the main function of neutrophils involves phagocytosis of
bacteria and killing of phagocytized and extracellular bacteria
by anti-bacterial enzymes and reactive oxygen species [1]. Be-
sides this role in innate immune defense, neutrophils have also
been implicated in the modulation of adaptive immune re-
sponses. Through the release of chemokines such as MIP-1a,
MIP-3a andMIP-3b and chemotactic peptides such as a-defen-
sin neutrophils are able to selectively attract other immune cells
like T cells, monocytes, macrophages and dendritic cells (DCs)
[2–4]. Moreover, in mice, eﬀective T cell responses against Can-
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doi:10.1016/j.febslet.2005.09.089depend on the presence of neutrophils [5–7]. Depletion of neu-
trophils abolishes polarization of T cells towards T helper 1
(Th1) cells and results in development of ineﬀective Th2 re-
sponses [5–7]. Recently, we have shown in humans that neutro-
phils may modulate T cell responses through interactions with
DCs [8]. DCs are antigen-presenting cells that play a pivotal role
in the induction of T cell responses, as they capture pathogens in
the periphery, carry these to the lymph nodes, and present pep-
tides derived from these pathogens to T cells [9]. DCs require
maturation signals to eﬀectively stimulate T cells.We and others
have shown that activated neutrophils are able to induce matu-
ration of DCs [8,10]. Furthermore, the cross-talk with neutro-
phils induces DCs to strongly activate T cell proliferation and
to instruct Th1 polarization [8]. This indicates that neutrophils
may regulate adaptive immune responses indirectly through
interactions with DCs.
We have reported previously that the interaction between
DCs and neutrophils is mediated by DC-SIGN and Mac-1
(CD11b/CD18) [8]. Here, we describe that DC-SIGN not only
binds Mac-1, but also CEACAM1 on neutrophils. Similar to
Mac-1, CEACAM1 is a strong ligand of DC-SIGN, and bind-
ing of DC-SIGN to both Mac-1 and CEACAM1 is required to
establish cellular interactions with neutrophils. DC-SIGN is a
C-type lectin, and has speciﬁcity for high-mannose and Lewisx
moieties [11–13]. DC-SIGN mediates interactions of DCs with
ICAM-2 on endothelial cells and with ICAM-3 on T cells
through high-mannose moieties that are expressed on these
counterstructures [13,14]. In contrast, CEACAM1 has recently
been described to contain Lewisx moieties on neutrophils [15],
and interactions between DC-SIGN and neutrophil CEA-
CAM1 are completely mediated by these Lewisx moieties. This
indicates that interactions of DC-SIGN with Mac-1 and CEA-
CAM1 deﬁne a novel pathway of cellular adhesion between
DCs and neutrophils that may play a crucial role in bridging
the innate and the adaptive immune response.2. Materials and methods
2.1. Antibodies and reagents
The following monoclonal antibodies were used: 12A2 (mouse IgG1
isotype control) [16], F3 (mouse IgM isotype control, Calbiochem, La
Jolla, CA), SPV-L7 (LFA-1) [17], KIM225 (Mac-1, kind gift of M.
Robinson, Celltech Inc., Slough, UK), CLB-gran/10 (CEACAM1,
CEACAM3 and CEACAM6, Sanquin, Amsterdam, Netherlands),
col-1 (CEACAM3, Beckton Dickinson, San Jose, CA), 9A6 (CEA-
CAM6, Genovac GmbH, Freiburg, Germany), 6H3 (Lewisx, kind gift
of B.J. Appelmelk, VU University Medical Center, Amsterdam, Neth-
erlands), AZN-D1 (DC-SIGN) [13] and AZN-D2 (DC-SIGN andblished by Elsevier B.V. All rights reserved.
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DC-SIGN (aa residues 64–404) fused at the C terminus to the Fc do-
main of human IgG1 [18]. DC-SIGN-Fc was produced in Chinese
hamster ovary K1 cells after transfection with the DC-SIGN-Sig-
pIgG1-Fc vector (20 lg). We used ICAM-3-Fc (kind gift of D.L. Sim-
mons, Celltech Inc., Slough, UK) that contains an Fc-domain of the
same isotype as a negative control (control-Fc).
2.2. Cells
Stable transfectants of K562 expressing wildtype or mutant DC-
SIGN were obtained by electroporation of pRC-CMV-DC-SIGN
(400 V, 960 lF) as described [18,19]. EBV-DC-SIGN and EBV-L-
SIGN were generated by lentiviral transduction of EBV cells by
LV-DC-SIGN and LV-L-SIGN, respectively [20]. Lipofectamin
(Invitrogen, Carlsbad, CA) transfection of CHO cells with pRC-
CMV-DC-SIGN was used to create CHO-DC-SIGN. Neutrophils
were isolated from fresh blood of healthy volunteers. After Ficoll gra-
dient centrifugation neutrophils were cleared from contaminating
erythrocytes using erylysis buﬀer (155 mM NH4Cl, 10 mM KHCO3,
and 0.1 mM EDTA). Isolated neutrophils were over 95% pure (data
not shown). Immature DCs were cultured from monocytes as
described [21,22]. Brieﬂy, monocytes were isolated from buﬀy coats
of healthy donors by Ficoll centrifugation and MACS sorting for
the monocyte marker CD14 (Miltenyi Biotec, Bergisch Gladbach,
Germany). Isolated monocytes were cultured for seven days on RPMI
1640 10% FCS in the presence of IL-4 (600 U/ml) and GM-CSF
(800 U/ml) to obtain 95% pure cultures of immature DCs. Immature
DCs expressed high levels of DC-SIGN, low levels of CD80, CD86
and MHC class II and did not express the DC maturation marker
CD83 (data not shown).
2.3. Immunoblotting
Neutrophils were lyzed in lysis buﬀer (1% Triton-X-100, 10 mM
TEA pH 8.2, 150 mM NaCl, 1 mMMgCl2, and 1 mM CaCl2) contain-
ing a cocktail of EDTA-free protease inhibitors (Roche Diagnostics,
Penzberg, Germany) for 1 h at 4 C. CEACAM1 and Mac-1 were
immunoprecipitated from neutrophil lysates with anti-CEACAM1
and anti-Mac-1 antibodies coated onto protA sepharose beads (CL-
4B, Pharmacia, Uppsala, Sweden). Immunoprecipitated CEACAM1
was run on SDS–PAGE (7% gel, reduced conditions), transferred onto
blot, and stained with DC-SIGN-Fc and secondary peroxidase-conju-
gated goat anti-human antibodies (Jackson ImmunoResearch Lab.
Inc., West Grove, PA) to determine DC-SIGN-Fc adhesion to CEA-
CAM1 and Mac-1. Similarly, DC-SIGN ligands were immunoprecip-
itated with DC-SIGN-Fc coated onto protA sepharose beads
(CL-4B, Pharmacia), and immunoblotted with anti-CEACAM1 and
anti-Mac-1 antibodies and secondary peroxidase-conjugated goat
anti-mouse antibodies (Jackson ImmunoResearch Lab. Inc.).
2.4. ELISA
The ELISA to analyze DC-SIGN-Fc binding to native ligands from
neutrophils was performed as described [8]. Brieﬂy, goat anti-mouse
antibodies (4 lg/ml, Jackson Immunoresearch Lab. Inc.) were coated
onto ELISA plates (NUNC maxisorp, Nalge Nunc Int., Rochester,
NY) for 1 h at 37 C followed by incubation with TSM (20 mM Tris–
HCl, pH 8.0, 150 mM NaCl, 1 mM CaCl2, and 1 mM MgCl2) 1%
bovine serum albumin (BSA) for 30 min at 37 C. Next, the ELISA
plate was incubated for 1 h at 37 C with mouse antibodies (1 lg/ml)
directed against the indicated antigens, washed, and incubated for
18 h at 4 C with neutrophil lysate (20 · 106 cells/ml) to allow capture
of neutrophil antigens. DC-SIGN-Fc (1 lg/ml) was added and allowed
to bind for 2 h at room temperature. Unbound DC-SIGN-Fc was
washed away and adhesion was determined using a peroxidase-conju-
gated goat anti-human Fc antibody (Jackson Immunoresearch Lab.
Inc.) that was incubated for 30 min at room temperature. Similarly,
the expression of Lewisx on neutrophil-derived antigens was determined
using anti-Lewisx antibodies and secondary goat anti-mouse IgM anti-
bodies (Nordic Immunologic Laboratories, Tilburg, Netherlands).
2.5. Fluorescent bead adhesion
Neutrophil-derived DC-SIGN ligands were coated onto carboxylate-
modiﬁed TransFluoSpheres (488/645 nm, 1.0 lm, Molecular Probes,
Eugene, OR) as described previously [8,23]. Brieﬂy, streptavidin wascovalently coupled onto TransFluoSpheres as described by manufac-
turer. To enable coupling of DC-SIGN ligands from neutrophils, strep-
tavidin-coated beads were allowed to bind to biotinylated goat anti-
mouse Fc Fab2 fragments (10 lg/ml, Jackson ImmunoResearch Lab.
Inc.) for 2 h at 37 C in PBS 0.5% BSA. Subsequently, beads were
washed, incubated for 18 h at 4 C with mouse antibodies directed
against CEACAM1 or Mac-1, washed again, and incubated for 48 h
at 4 C with neutrophil lysate (20 · 106 cells/ml) to capture CEACAM1
or Mac-1 onto the beads. After preincubation with blocking anti-DC-
SIGN and anti-L-SIGN antibodies (20 lg/ml), mannan (50 lg/ml) or
EGTA (10 mM) for 10 min at room temperature in TSM 0.5% BSA,
cells were incubated with ligand-coated beads for 45 min at 37 C. After
washing, bead adhesion to the cells was analyzed by ﬂow cytometry
(FACS Calibur, Beckton Dickinson, San Jose, CA).
2.6. Cell–cell adhesion
To examine cellular interactions of DC-SIGN with neutrophils
CHO and CHO-DC-SIGN were grown overnight to conﬂuent cultures
in ﬂat-bottom 96-wells plates. Neutrophils were labeled with the green
ﬂuorescent dye Calcein-AM (1 lM, Molecular Probes) for 15 min at
37 C and incubated with mock and DC-SIGN transfected CHO cells
in TSM 0.5% BSA for 2 h at 37 C. To determine speciﬁc adhesion the
CHO transfectants were preincubated with anti-DC-SIGN, anti-Mac-1
or anti-CEACAM1 antibodies (20 lg/ml) for 30 min at 37 C. Un-
bound neutrophils were washed away, and remaining cells were lyzed
in lysis buﬀer (50 mM Tris–HCl, pH 8.0, and 0.1% SDS). Cell–cell
adhesion was measured by ﬂuorimetry of cell lysates at 488 nm (Fluo-
star Galaxy, BMG Labtechnologies Inc., Durham, NC). Cell–cell
adhesion was calculated as the percentage of total added neutrophils
that was considered as 100% adhesion.
2.7. Co-culture experiments
Neutrophils were pulsed for 1 h with LPS (100 ng/ml), rigorously
washed, and then incubated with allogenic immature DCs at a ratio
of 3:1 for 18 h at 37 C in RPMI 1640 10% FCS. Maturation of
DCs was assessed by ﬂow cytometry analysis of the expression
of the DC maturation marker CD83, and analysis of the production
of IL-12p40 in the supernatant using sandwich ELISA according to
the manufacturers protocol (Biosource, Nivelles, Belgium).3. Results
3.1. DC-SIGN binds Mac-1 and CEACAM1 on neutrophils
Recently, we have demonstrated that DCs interact with neu-
trophils through binding of DC-SIGN to Mac-1, and that the
DC-neutrophil interaction results in maturation of DCs and
predisposes DCs to DC1 that induce Th1 responses [8]. DC-
SIGN has speciﬁcity for Lewisx moieties that are expressed at
high levels on neutrophils [11,24]. These Lewisx structures are
present on few proteins on neutrophils, in particular on pro-
teins of 100 and 160 kD (Fig. 1A). Mac-1 is a carrier molecule
of Lewisx moieties on neutrophils and contains Lewisx on both
the a-chain (CD11b) of 160 kD and the b-chain (CD18) of
100 kD [25,26]. We have shown before that binding of DC-
SIGN to neutrophil Mac-1 is mediated in part through its
Lewisx moieties [8]. Neutrophils express Lewisx not only on
Mac-1 but also on CEACAM1 [15,26]. Therefore, we investi-
gated whether CEACAM1 is also an important ligand of
DC-SIGN on neutrophils. We have shown that DC-SIGN
binds a 160 kD ligand on neutrophils [8], of which the molecu-
lar weight not only corresponds to that of the previously
identiﬁed DC-SIGN-ligand Mac-1, but also to that of the sim-
ilarly-sized glycoprotein CEACAM1 (Fig. 1A). Although both
the a- and b-chain of Mac-1 express Lewisx, DC-SIGN specif-
ically binds the a-chain of Mac-1, suggesting that expression of
Lewisx does not fully predict binding of DC-SIGN [8]. To
investigate whether DC-SIGN binds both CEACAM1 and
Fig. 1. CEACAM1 is an alternative DC-SIGN ligand on neutrophils. (A) Neutrophil lysate was immunoblotted with control-Fc, DC-SIGN-Fc,
mouse IgG1 isotype control antibodies, anti-CEACAM1, -3 and -6 antibodies (on immunoblot the anti-CEACAM1, -3 and -6 speciﬁc antibody
CLB-gran/10 only recognizes CEACAM1 [53]), anti-Mac-1 antibodies, mouse IgM isotype control antibodies and anti-Lewisx antibodies. (B)
Neutrophil lysate was immunoprecipitated using mouse IgG1 isotype control antibodies, anti-CEACAM1, -3 and -6 antibodies and anti-Mac-1
antibodies, and immunoblotted with DC-SIGN-Fc. (C) Immunoblots with mouse IgG1 isotype control antibodies, anti-CEACAM1, -3 and -6
antibodies and anti-Mac-1 antibodies were performed on neutrophil lysate that had been immunoprecipitated using control-Fc and DC-SIGN-Fc.
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using anti-CEACAM1 and anti-Mac-1 antibodies and ana-
lyzed binding to DC-SIGN-Fc on blot (Fig. 1B). DC-SIGN
bound to CEACAM1 as well as to the a-chain, but not to the
b-chain, of Mac-1 (Fig. 1B). The anti-CEACAM1 antibody
also recognizes the homologous molecules CEACAM3 and -6
of 30 and 90 kD respectively, but they are not bound by DC-
SIGN (Fig. 1B). Thus, both CEACAM1 andMac-1 are ligands
of DC-SIGN on neutrophils, and they may compete for bind-
ing to DC-SIGN. To examine whether DC-SIGN binds both
ligands simultaneously, neutrophil lysate was immunoprecipi-
tated with DC-SIGN-Fc, and analyzed on immunoblot for
the presence of CEACAM1 and Mac-1. We were able to detect
CEACAM1 as well asMac-1 on immunoblot (Fig. 1C), demon-
strating that under these settings both DC-SIGN ligands do not
outcompete each other. This indicates that interactions be-
tween neutrophils and DCs require binding of DC-SIGN to
both CEACAM1 and Mac-1.
3.2. CEACAM1 interacts with DC-SIGN through Lewisx
moieties
We have recently developed an ELISA-based bindings as-
say that enables rapid screening of DC-SIGN-Fc binding tomultiple potential ligands isolated from a native source [8].
Neutrophils express CEACAM1, -3, -6 and -8 of the immuno-
globulin family of CEA-related proteins [27]. We were able to
detect CEACAM1, -3 and -6 in neutrophil lysate using sand-
wich ELISA (data not shown). Capture of CEACAM1, -3
and -6 from neutrophil lysate and detection with DC-SIGN-
Fc showed that DC-SIGN binds CEACAM1 and possibly
to the homologous molecules CEACAM3 and -6 (Fig. 2A).
Binding of DC-SIGN-Fc was not observed to either CEA-
CAM3 or -6 that was captured from neutrophil lysate using
speciﬁc antibodies (Fig. 2A), demonstrating that only CEA-
CAM1 is a ligand of DC-SIGN. The carbohydrate recogni-
tion domain of DC-SIGN has speciﬁcity for high-mannose
moieties and Lewis antigens [11,12]. As has been reported,
CEACAM1 from neutrophils contains Lewisx moieties
[15,26]. To examine the contribution of Lewisx moieties on
CEACAM1 in binding to DC-SIGN, CEACAM1 was treated
with a1-3,4-fucosidase that speciﬁcally removes the fucose
moiety from Lewisx that is essential for DC-SIGN binding
[28]. Sandwich ELISA for CEACAM1 demonstrated that
treatment with a1-3,4-fucosidase did not disrupt integrity of
CEACAM1 (data not shown). The enzymatic treatment
removed the Lewisx epitope from CEACAM1 (Fig. 2B),
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Fig. 2. DC-SIGN binds Lewisx on neutrophil CEACAM1. (A)
Binding of DC-SIGN-Fc to neutrophil-derived CEACAM1, -3 and
-6 was analyzed using ELISA. Results are representative of three
independent experiments. (B) Expression of Lewisx was measured
using ELISA on neutrophil-derived LFA-1 (negative control) and
CEACAM1, -3 and -6 that was left untreated, or that had been treated
after capture onto ELISA plates for three days with enzyme buﬀer
(50 mM sodium phosphate buﬀer pH 5.0) in the presence or absence of
a1-3,4-fucosidase (from Xanthomonas, Calbiochem, La Jolla, CA) at
37 C. Similar results were obtained in three independent experiments.
(C) CEACAM1, -3 and -6 was incubated for three days in ELISA
buﬀer, or in enzyme buﬀer with and without a1-3,4-fucosidase at
37 C, and analyzed for binding to DC-SIGN-Fc using ELISA.
Experiment was performed three times with similar results. (D) LFA-1
and CEACAM1, -3 and -6 were captured from neutrophil lysate,
incubated with IgM isotype control antibodies or blocking anti-Lewisx
antibodies, and binding to DC-SIGN-Fc was examined using ELISA.
Three independent experiments with similar results were performed.
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phil-derived CEACAM1, demonstrating that Lewisx moieties
mediate binding of DC-SIGN to CEACAM1 on neutrophils
(Fig. 2C). In addition, blocking anti-Lewisx antibodies inhib-
ited binding of DC-SIGN-Fc to CEACAM1 from neutro-
phils, conﬁrming that Lewisx moieties on CEACAM1 are
essential for DC-SIGN binding (Fig. 2D). In contrast to
DC-SIGN binding to neutrophil CEACAM1, binding of
DC-SIGN to Mac-1 on neutrophils was only partially depen-
dent on Lewisx [8].
3.3. Cell-speciﬁc glycosylation of CEACAM1 regulates binding
of DC-SIGN
In contrast to CEACAM3 and -6, CEACAM1 is not only
expressed on neutrophils, but also on activated T cells
[29,30]. However, CEACAM1 on activated T cells is diﬀer-
ently glycosylated and does not contain Lewisx [30]. Indeed,
activation of T cells with PHA and IL-2 induced expression
of CEACAM1 on T cells at day 5 and 8 after stimulation
(Fig. 3A), but did not upregulate Lewisx expression on these
T cells (Fig. 3B). We were able to capture and detect CEA-
CAM1 from neutrophils and T cells using sandwich ELISA
(data not shown). In contrast to neutrophil-derived CEA-
CAM1, CEACAM1 from activated T cells did not bind to
DC-SIGN, which correlates with the expression levels of Le-
wisx on CEACAM1 (Fig. 3C). Thus, CEACAM1 is diﬀer-
ently glycosylated on neutrophils and T cells, and the
glycosylation pattern of CEACAM1 on these cell types reg-
ulates binding of DC-SIGN.
3.4. Cellular DC-SIGN but not L-SIGN binds neutrophil-derived
CEACAM1
DC-SIGN is present at high levels on monocyte-derived
immature DCs [13]. On these cells, DC-SIGN is the dominant
receptor that binds glycoconjugates of Lewisx, and Lewisx-
expressing pathogens such as Schistosoma mansoni and Helico-
bacter pylori [11,31]. Since Lewisx on CEACAM1 mediates
binding to DC-SIGN, we investigated the adhesion of imma-
ture DCs to neutrophil CEACAM1. Therefore, we captured
CEACAM1 from neutrophils onto ﬂuorescent beads and ana-
lyzed binding of these beads to immature DCs. The antibody
used to capture CEACAM1 onto the beads also recognizes
CEACAM3 and -6, but these molecules do not interact with
DC-SIGN (Fig. 2A). Monocyte-derived immature DCs bound
neutrophil CEACAM1, and anti-DC-SIGN antibodies, the
polysaccharide mannan, and the Ca2+ chelator EGTA blocked
adhesion, demonstrating that these cells use DC-SIGN as an
adhesion receptor for neutrophil CEACAM1 (Fig. 4A). The
C-type lectin domain of DC-SIGN is involved in binding of
neutrophil CEACAM1, since mutation of essential amino
acids within this domain that mediate ligand binding and posi-
tioning of the Ca2+ ions abrogate adhesion of neutrophil CEA-
CAM1 to DC-SIGN (Fig. 4B) [12,18]. L-SIGN (DC-SIGNR)
is a close homologue of DC-SIGN that is not expressed on
DCs, but on endothelial cells in liver and lymph node
[16,32]. Although the binding speciﬁcities of DC-SIGN and
L-SIGN are highly similar, Lewisx moieties are bound by
DC-SIGN, but not by L-SIGN [33,34]. Since binding of neu-
trophil-derived Mac-1 and CEACAM1 to DC-SIGN is medi-
ated by Lewisx, we analyzed adhesion of these proteins to
L-SIGN. Therefore, we coated Mac-1 and CEACAM1 from
neutrophils onto ﬂuorescent beads, and measured adhesion
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Fig. 4. CEACAM1 is recognized by cellular DC-SIGN, but not by
cellular L-SIGN. (A) Neutrophil-derived CEACAM1, -3 and -6 was
captured onto ﬂuorescent beads, and the percentage of immature DCs
that bound one or multiple beads was examined using FACS analysis.
Speciﬁcity of adhesion was determined using isotype control antibod-
ies, anti-DC-SIGN antibodies, mannan and EGTA. Similar results
were obtained in three independent experiments. (B) Fluorescent beads
coated with neutrophil CEACAM-1, -3 and -6 were incubated with
mock-transfected K562 cells and with K562 cells transfected with
wildtype or mutant DC-SIGN containing mutations in the C-type
lectin domain, and adhesion was measured using FACS analysis.
Results are representative of three independent experiments. (C)
Adhesion of beads coated with Mac-1 or CEACAM-1, -3 and -6 from
neutrophils to EBV cells transduced with DC-SIGN or L-SIGN was
analyzed using FACS. Experiment was performed three times with
similar results.
Fig. 3. T cell-derived CEACAM1 does not bind DC-SIGN. (A and B)
Peripheral blood lymphocytes (PBLs) were activated with IL-2
(400 U/ml) and PHA (0.2 lg/ml) and expression of isotype controls
(thin lines) and (A) CEACAM-1 (thick lines) and (B) Lewisx (thick
lines) was determined at day 0, 2, 5 and 8 using FACS analysis. (C)
Binding of DC-SIGN-Fc to CEACAM-1, -3 and/or -6 derived from
neutrophils and CEACAM1 from PBLs activated for 0, 2, 5 and 8 days
with IL-2 and PHA was measured using ELISA. Experiment was
performed three times with similar results.
K.P.J.M. van Gisbergen et al. / FEBS Letters 579 (2005) 6159–6168 6163of these beads to EBV-DC-SIGN and EBV-L-SIGN by FACS
analysis. Neutrophil Mac-1 bound to DC-SIGN as well as L-
SIGN, although adhesion of Mac-1 to L-SIGN was reduced
compared to DC-SIGN, whereas neutrophil CEACAM1
bound to DC-SIGN but not to L-SIGN (Fig. 4C). This corre-
sponds with the partial Lewisx-dependency of DC-SIGN bind-
ing to Mac-1 and the complete Lewisx-dependency of DC-
SIGN binding to CEACAM1 [8], and indicates that Mac-1
contains glycans other than Lewisx that are involved in binding
to L-SIGN and DC-SIGN.3.5. DC-SIGN mediates cellular interactions with resting and
activated neutrophils through Mac-1 and CEACAM-1
Neutrophil activation induces degranulation, and this results
in the release of anti-microbial components and the upregula-
tion of membrane molecules. The expression levels of CEA-
CAM1, -3 and/or -6 and Mac-1, but not of LFA-1 are
increased on neutrophils that are activated with both LPS
and FMLP (Fig. 5A). This suggests that activated neutrophils
bind stronger to DC-SIGN than resting neutrophils. Indeed,
binding of DC-SIGN-Fc is increased to LPS- and FMLP-acti-
vated neutrophils compared to resting neutrophils (Fig. 5B).
Previously, we have shown that DC-SIGN mediates cellular
interactions between immature DCs and neutrophils [8]. To
examine whether binding of DC-SIGN to both Mac-1 and
Fig. 5. CEACAM1 and Mac-1 on resting and activated neutrophils are involved in cellular interactions with DC-SIGN. (A) Resting neutrophils and
activated neutrophils that were incubated for 1 h with LPS and in the ﬁnal 15 min with FMLP at 37 C were analyzed on FACS for expression of
isotype control (thin line), LFA-1, Mac-1, or CEACAM-1, -3 and -6 (thick line). Insets represent mean ﬂuorescence intensity. (B) Binding of DC-
SIGN-Fc to resting and activated neutrophils was examined using FACS analysis (thick line). Speciﬁcity of binding was determined using anti-DC-
SIGN antibodies (thin line). Insets represent mean ﬂuorescence intensity. (C) CHO and CHO-DC-SIGN cells were incubated with Calcein-AM
labeled resting or activated neutrophils, and cellular adhesion was examined after washing and cell lysis using ﬂuorimetry. Speciﬁcity of adhesion was
determined using isotype control antibodies and blocking antibodies against DC-SIGN, CEACAM1, -3 and -6, or Mac-1. The experiment was
performed in triplicate three times with similar results. Error bars represent standard error of the mean of triplicates. (D and E) DCs were co-cultured
with activated neutrophils during 18 h to investigate neutrophil-induced DC maturation. (D) Expression of the DC maturation marker CD83 was
examined using FACS analysis and (E) production of the cytokine IL-12p40 was analyzed within the supernatants using sandwich ELISA. Speciﬁcity
of the interaction between DCs and neutrophils was determined with blocking antibodies against DC-SIGN, CEACAM-1, -3 and -6, or Mac-1.
Similar results were obtained in three independent experiments. Error bars represent standard error of the mean of triplicates.
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neutrophils, we incubated neutrophils with CHO transfectants
expressing DC-SIGN, and analyzed adhesion in the absence
and presence of blocking antibodies. In contrast to the paren-
tal CHO cells, DC-SIGN-expressing CHO transfectants
strongly interacted with both resting and activated neutrophils
(Fig. 5C). Although DC-SIGN-Fc bound stronger to activated
than to resting neutrophils, activation of neutrophils did not
further enhance binding of neutrophils to CHO-DC-SIGN
(Fig. 5C). Adhesion was inhibited in the presence of blocking
anti-DC-SIGN antibodies, demonstrating that DC-SIGN
mediated the cellular interaction with neutrophils (Fig. 5C).
Preincubation with both anti-Mac-1 and anti-CEACAM1, -3
and -6 antibodies strongly blocked neutrophil adhesion to
CHO-DC-SIGN, in contrast to preincubation with either
anti-Mac-1 or anti-CEACAM1, -3 and -6 antibodies
(Fig. 5C). Thus, binding to both Mac-1 and CEACAM1 is re-
quired for DC-SIGN to mediate cellular interactions with neu-
trophils. Since we have observed simultaneous binding of the
antibodies and DC-SIGN to Mac-1 and CEACAM1 in ELISA
(Fig. 2A), it is unlikely that they recognize the same epitope.
This indicates that the inhibition of the anti-Mac-1 and anti-
CEACAM1, -3 and -6 antibodies in cellular adhesion is
through steric hindrance. Activated but not resting neutrophils
induce upregulation of the DC maturation marker CD83 and
production of IL-12p40 by DCs through DC-SIGN-dependent
cellular interactions (Fig. 5D and E) [8]. We investigated
whether neutrophil-induced DC maturation required binding
of DC-SIGN to both Mac-1 and CEACAM1 using blocking
antibodies against these DC-SIGN ligands. Surprisingly, neu-
trophil-induced upregulation of CD83 on DCs was not inhib-
ited with anti-Mac-1 and anti-CEACAM1, -3 and -6
antibodies (Fig. 5D). In contrast, neutrophil-induced IL-
12p40 release by DCs was sensitive to anti-Mac-1, but not
anti-CEACAM1, -3 and -6 antibodies (Fig. 5E). This may indi-
cate that binding of DC-SIGN to Mac-1 and CEACAM1 does
not play a role in the induction of DC maturation by neutro-
phils, and that DC-SIGN-Mac-1 interactions are more impor-
tant for neutrophils than DC-SIGN-CEACAM1 interactions
to induce IL-12p40 release by DCs.4. Discussion
Previously, we have shown that DCs interact with neutro-
phils through binding of DC-SIGN to Mac-1. The interaction
results in maturation of DCs and primes these DCs to induce
strong T cell responses of the T helper 1 type. Here, we have
identiﬁed CEACAM1 as an alternative ligand of DC-SIGN
on neutrophils. Both CEACAM1 and Mac-1 are essential li-
gands on neutrophils for DC-SIGN to establish cellular inter-
actions. DC-SIGN binds neutrophil-derived CEACAM1
through Lewisx moieties, but not high-mannose moieties. In
contrast to DC-SIGN, the homologous molecule L-SIGN does
not bind to CEACAM1 and poorly to Mac-1.
Neutrophils have a unique glycosylation pattern, and in
contrast to other leukocytes, express non-sialylated Lewisx
carbohydrates on the cell surface [24]. Little is known on the
regulation of this, but the diﬀerential expression of
fucosyltransferases likely plays a role. These enzymes incorpo-
rate a fucose through a3-linkage on the N-acetyl-glucosaminemoiety of a non-sialylated lactosamine unit to form a Lewisx
glycan. Neutrophils express high levels of Lewisx, but only
few proteins on neutrophils are carrier molecules of Lewisx,
and these include Mac-1 and CEACAM1 [15,25,26]. Cur-
rently, it is unknown what determines that particularly CEA-
CAM1 and Mac-1 on neutrophils express Lewisx epitopes.
Neutrophils express the fucosyltransferases 4 and 9 that may
be involved in Lewisx synthesis on neutrophil proteins [35],
but future research is required to determine whether they are
involved in the formation of Lewisx on CEACAM1 and
Mac-1. Previously, we have described that the neutrophil-spe-
ciﬁc glycosylation of Mac-1 enables DC-SIGN to bind Mac-1
on neutrophils, but not on other cells [8]. Similar to Mac-1,
CEACAM1 has a broad tissue expression and has been de-
scribed on other leukocytes besides neutrophils such as B cells,
a subset of NK cells and IL-2 activated T cells [30]. In contrast
to CEACAM1 on neutrophils, DC-SIGN did not bind to
CEACAM1 derived from PHA- and IL-2-activated T cells.
This supports that glycosylation of CEACAM1 is cell-speciﬁ-
cally regulated, and that expression of Lewisx on neutrophils
but not on activated T cells enables binding of DC-SIGN. In-
deed, inhibition with fucosidase treatment and anti-Lewisx
antibodies showed that binding of DC-SIGN to neutrophil
CEACAM1 critically depended on Lewisx moieties. Thus,
binding of DC-SIGN to neutrophil-speciﬁc glycosylation of
CEACAM1 may contribute together with DC-SIGN-Mac-1
interactions to cellular adhesion of immature DCs and neutro-
phils to enable cross-talk between the cells.
CEACAM1 belongs to a small subfamily of immunoglobu-
lins that in humans consists of CEACAM1 to -8 and 11 preg-
nancy speciﬁc glycoproteins. Neutrophils express the
CEACAM1 homologues CEACAM3, -6 and -8 besides CEA-
CAM1 [27]. Consistent with the absence of the DC-SIGN
adhesion determinant Lewisx on these molecules [36], DC-
SIGN did not bind to CEACAM1 homologues. Carcinoem-
bryonic antigen (CEA) is a homologue of CEACAM1 that
is not expressed on neutrophils, but on normal colon epithe-
lium and has retained or enhanced expression on colorectal
cancer cells [37]. Glycosylation of CEA is distinct on normal
and tumor colon epithelium, and the expression of Lewisx
and Lewisy on colorectal cancer is increased compared to
normal colon epithelium [38–41]. Consistent with its carbohy-
drate speciﬁcity, DC-SIGN binds to CEA from normal but
not tumor colon epithelium [42]. Thus, glycosylation modiﬁ-
cations that result in acquisition of Lewisx and Lewisy anti-
gens regulate binding of DC-SIGN to CEACAM1 and
homologues of CEACAM1.
Neutrophils induce DC maturation through DC-SIGN-
dependent interactions with immature DCs and the release
of TNF-a. DC-SIGN may establish a cellular contact zone
or synapse between neutrophils and DCs through interac-
tions with Mac-1 and CEACAM1 that enable eﬃcient tar-
geting of the DC maturation-inducing factor TNF-a to
DCs. [8]. We observed that binding to Mac-1 and CEA-
CAM1 is required for DC-SIGN to mediate cellular interac-
tions with neutrophils, indicating that these DC-SIGN
ligands are involved in the induction of DC maturation by
neutrophils. However, anti-Mac-1 and anti-CEACAM1 anti-
bodies did not block DC maturation, and anti-Mac-1 anti-
bodies, but not anti-CEACAM1 antibodies, inhibited IL-
12p40 release by DCs. Conclusions from these functional
experiments should be drawn with caution, since anti-CEA-
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activate neutrophils to release DC maturation factors such
as TNF-a. Indeed, CEACAM1 has been implicated in neu-
trophil activation. Although CEACAM1 contains a com-
plete inhibitory ITIM motif, and associates with the
phosphatases SHP-1 and SHP-2 in epithelial tumor cells
[43], it associates with the protein tyrosine kinases lyn and
hck in neutrophils [44]. Antibodies that target CEACAM1
potentiate the oxidative burst of neutrophils in response to
FMLP [45], induce degranulation of secondary granules con-
taining lactoferrin [46], increase LFA-1-mediated adhesion of
neutrophils to endothelium, and trigger upregulation of
Mac-1 and shedding of L-selectin [47]. Similarly, galectin-3
has been shown to bind CEACAM1 and to enhance the oxi-
dative burst in FMLP-activated neutrophils [48]. Galectin-3
is a C-type lectin that is released by macrophages under
inﬂammatory conditions, and in contrast to DC-SIGN has
high aﬃnity for b-galactoside in lactosamine glycans. This
may indicate that cross-talk between neutrophils and DCs
is bi-directional, and that DC-SIGN is involved in the
induction of neutrophil activation. However, we did not ob-
serve that DC-SIGN triggered stimulation of neutrophils
that results in production of oxygen radicals or degranula-
tion (data not shown). This may be explained by binding
of DC-SIGN to Lewisx on CEACAM1 that is a diﬀerent
epitope than those recognized by anti-CEACAM1 antibodies
or galectin-3. During infection, neutrophils are likely present
prior to the arrival of DCs, indicating that activation of
neutrophils by inﬂammatory mediators or pathogenic stimuli
is more important than activation by DCs. DC-SIGN not
only establishes cellular interactions with resting but also
with activated neutrophils. Mac-1 and CEACAM1 are
upregulated upon activation of neutrophils, and this results
in stronger binding of DC-SIGN to activated than to resting
neutrophils. Thus, DC-SIGN may not be involved in activa-
tion of neutrophils, but perhaps it plays a role in regulation
of later events such as neutrophil apoptosis, cytokine and
chemokine production by neutrophils, and diﬀerentiation
of neutrophils into DCs.
Neutrophils are very eﬃcient in degrading internalized
antigens in contrast to DCs that keep antigens intact for
prolonged periods in endocytic vesicles [49]. The DC-
SIGN-CEACAM1 mediated interaction may enable DCs to
transfer captured bacteria to neutrophils, which would facil-
itate eﬃcient internalization and destruction of the bacteria.
Indications that neutrophils phagocytize bacteria tethered to
other cells have been found in rat liver, in which it was
shown that intravenously administered Listeria monocytoge-
nes were initially bound to Kupﬀer cells, and thereafter
accumulated within neutrophils [50]. Phagocytosis and pro-
cessing of pathogens by neutrophils may provide a rich
source of pathogen-derived peptides that enables DCs to
speciﬁcally activate pathogen-speciﬁc T cells. Indeed, some
evidence indicates that antigens that are phagocytized and
processed by neutrophils are transferred to DCs for presen-
tation to T cells [51,52]. Here, we have established CEA-
CAM1 as a novel ligand of DC-SIGN that besides Mac-1
may be involved in interactions between neutrophils and
DCs to enable cross-talk between the cells. It will be inter-
esting to examine whether interactions of CEACAM1 and
Mac-1 with DC-SIGN play a role in antigen transfer from
DCs to neutrophils and vice versa.Acknowledgments: K.P.J.M.v.G is supported by the Dutch Scientiﬁc
Research (NWO; Grant No. 901-07-220) and I.S.L. is supported by
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